Vertex Among Four Hopefuls Seeking EMA's Elusive Speedy Review

 
• By Neena Brizmohun

Vertex’s triple combination regimen for cystic fibrosis and two Ebola vaccines from Janssen are among the latest potential new products being considered for accelerated assessment by the European Medicines Agency.

Racing car
The EMA is considering five new requests for fast-track review. • Source: Shutterstock

More from Archive

More from Pink Sheet